We are live on ! Find out more
REVBW icon

Revelation Biosciences Warrant
REVBW

11 hedge funds and large institutions have $6.76K invested in Revelation Biosciences Warrant in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% less funds holding

Funds holding: 13 → 11 (-2)

53.6% less ownership

Funds ownership: 75.62% → 22.02% (-54%)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

89% less capital inflows, than outflows

Capital inflows: $484 | Capital outflows: $4.27K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
11
Holders Change
-2
Holders Change %
-15.38%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wolverine Asset Management
Wolverine Asset Management
Illinois
+$381
2
Citadel Advisors
Citadel Advisors
Florida
+$103

Top Sellers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
-$2.07K
2
Pine Valley Investments
Pine Valley Investments
New Jersey
-$501
3
Walleye Trading
Walleye Trading
New York
-$135
4
Two Sigma Securities
Two Sigma Securities
New York
-$64
5
Clear Street
Clear Street
New York
-$2

REVBW Hedge Fund Activity: Q4 2024 in Review

11 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q4 2024, worth a combined $6.76K — down 64% from $18.6K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of REVBW and 0 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 2 added.

The largest buyer was Wolverine Asset Management, adding an estimated $381. The largest seller was Walleye Capital, cutting an estimated $2.07K.

  • 11 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q4 2024, down from 13 in Q3 2024.
  • Funds reported $6.76K of Revelation Biosciences Warrant stock for Q4 2024, down 64% quarter-over-quarter.
  • 0 funds opened new Revelation Biosciences Warrant positions in Q4 2024 and 2 closed out, a net change of -2 holders.
  • The largest Revelation Biosciences Warrant buyer in Q4 2024 was Wolverine Asset Management, an estimated $381 added.
  • The largest Revelation Biosciences Warrant seller in Q4 2024 was Walleye Capital, an estimated $2.07K sold.

Based on aggregated 13F filings for Q4 2024.